ClinicalTrials.gg
Enrolling by invitationNCT07341789MECHEPSUpdated Jan 14, 2026

Effects of Vitamin B12 and Natural Orange Extract, and Their Combination on Physical and Mental Performance

An interventional study of Vitamin B 12 and Natural orange extract in Vitamin b12, Supplementation During Endurance Performance and Flavonoids, sponsored by Francisco Javier Martínez Noguera. Enrolling by invitation at 1 site in Spain. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by Francisco Javier Martínez Noguera · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

The aim of this study was to determine the effects of a new formulation of vitamin B12, natural orange extract, and their combination on physical and mental performance.

Read the detailed description

A triple-blind, randomized, crossover clinical trial will be conducted with three experimental phases (vitamin B12 + natural orange extract, natural orange extract, vitamin B12) and one control phase (placebo), including evaluations of the acute effect after a loading phase (three intakes, one per day including the test day).

Participants

The sample will consist of 20 well-trained male cyclists (road, MTB, or triathlon), training 3-6 sessions per week, aged between 18 and 45 years. The inclusion criteria will be:

  • Healthy male (to be certified through medical examination and health analysis).
  • Aged 18-45 years.
  • Well-trained (3-6 training sessions per week).
  • Habitual consumer of citrus fruits (orange, mandarin, lemon, or grapefruit, either whole or as juice).

Tests

  • General health analysis: A general blood test (including standard biochemistry and complete blood count) will be performed during the recruitment phase.
  • Medical examination: A cardiorespiratory assessment at rest will be conducted to rule out any underlying pathology.
  • Specific performance-related blood analysis: Conducted at four time points (total of eight measurements): baseline during recruitment, pre- and post-test in each condition (supplement / placebo). Parameters will include: complete blood count, ferritin, CK, LDH, vitamin B12, transaminases, reticulocytes, homocysteine, C-reactive protein, IL-6, methylmalonic acid, holo-transcobalamin II, 8-OHdG (8-hydroxy-2'-deoxyguanosine), dopamine, serotonin, and Brain-Derived Neurotrophic Factor (BDNF).
  • Anthropometry: Determination of body composition parameters to characterize the sample.
  • Wingate test: Conducted using the standard load protocol, consisting of five maximal 30-second sprints with 3-minute recovery intervals between repetitions.
  • Mental fatigue test using light-based reaction tasks: The time required to complete a light reaction sequence will be measured before and after the fatigue protocol.
  • Genetic test: A saliva sample will be collected to analyze genetic profiles related to food intolerances and vitamin absorption. The objective is to identify potential explanations for interindividual differences in absorption capacity.
02

Conditions studied

  • Vitamin b12
  • Supplementation During Endurance Performance
  • Flavonoids
  • Mental Fatigue
  • Biomarker Feedback

Browse trials for

Keywords

  • Ergogenic aids
  • Wingate test
  • Vitamin B12
  • Polyphenols
  • Performance
  • Natural orange extract
03

In context

Mental Fatigue

177 studies on the registry are indexed under Mental Fatigue; 55 are open to participants now.

This study's planned enrollment of 20 is below the median of 45 across 145 interventional studies indexed under Mental Fatigue.

Browse Mental Fatigue studies →

Lead sponsor

Francisco Javier Martínez Noguera is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy male (to be certified through medical examination and health analysis).
  • Aged 18-45 years.
  • Well-trained (3-6 training sessions per week).
  • Habitual consumer of citrus fruits (orange, mandarin, lemon, or grapefruit, either fresh or juiced).

Exclusion criteria

Exclusion Criteria:

  • Smokers or regular alcohol drinkers.
  • Persons suffering from a metabolic, cardiorespiratory or digestive pathology or anomaly.

digestive system.

  • People who have suffered an injury in the last 6 months that limits the performance of the study tests. of the study tests.
  • People taking supplements or medication in the 2 weeks before the start of the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Vitamin B12

    This group will take 1.0 mg of vitamin B12 two days before the tests and 3 hours before each test. Therefore, the supplementation will last 3 days in total.

    Dietary Supplement: Vitamin B 12

  • Experimental
    Natural orange extract

    This group will take 500 mg of natural orange extract two days before the tests and 3 hours before each test. Therefore, the supplementation will last 3 days in total.

    Dietary Supplement: Natural orange extract

  • Experimental
    Vitamin B12 + natural orange extract

    This group will take 1.0 mg of vitamin B12 + 500 mg of natural orange extract two days before the tests and 3 hours before each test. Therefore, the supplementation will last 3 days in total.

    Combination Product: Vitamina B12 + natural orange extract

  • Placebo comparator
    Placebo

    This group will take 500 mg of microcrystalline cellulose two days before the tests and 3 hours before each test. Therefore, the supplementation will last 3 days in total.

    Dietary Supplement: Microcrystalline Cellulose

Interventions

  • Dietary supplementVitamin B 12

    Subjects in this group will intake 1 mg/day of vitamin B12.

    Also known as: Vitamin B12

  • Dietary supplementNatural orange extract

    Subjects in this groups will intake 500 mg/day of natural orange extract.

  • Combination productVitamina B12 + natural orange extract

    This group will take the combination of vitamin B12 and Vitamina B12 (1 mg/day) + natural orange extract (500 mg/day).

  • Dietary supplementMicrocrystalline Cellulose

    Microcrystalline cellulose was used, this molecule was selected to avoid affecting the glycemia, as it can occur with dextrose or maltodextrin.

06

What researchers measure

Primary outcomes

  1. Wingate test

    This test consists of 5 efforts of 30 seconds at maximum intensity with a recovery of 3 minutes on a bike. In this test the peak and average power of each effort and the total average will be evaluated. In addition, the time to maximum peak power and the fatigue index.

    Time frame: Throughout study completion, an average of 4 weeks

Secondary outcomes

  1. Mental fatigue test

    In this test, we will measure the speed of reaction in the resolution of a sequence of lights set by the researcher before and after the end of the performance test.

    Time frame: Throughout study completion, an average of 4 weeks

  2. Hematological Parameters

    A complete blood count (including red blood cell count, hemoglobin, hematocrit, and white blood cell count) will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  3. Iron Status Marker

    Serum ferritin concentration measured as an indicator of iron status, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  4. Vitamin B12 Status - Serum Vitamin B12

    Serum vitamin B12 concentration measured from venous blood samples, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  5. Functional Vitamin B12 Biomarkers

    Description: Plasma methylmalonic acid, holo-transcobalamin II, and homocysteine concentrations assessed as functional biomarkers of vitamin B12 status, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  6. Muscle Damage Markers

    Description: Serum creatine kinase (CK) and lactate dehydrogenase (LDH) concentrations measured as indicators of exercise-induced muscle damage, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  7. Hepatic Enzymes

    Description: Serum glutamic-oxaloacetic transaminase (GOT/AST) and glutamic-pyruvic transaminase (GPT/ALT) concentrations, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  8. Inflammatory Marker

    Description: Serum C-reactive protein (CRP) concentration measured as a marker of systemic inflammation, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  9. Oxidative Stress Marker

    Description: Plasma 8-hydroxy-2-deoxyguanosine (8-OHdG) concentration measured as a marker of oxidative DNA damage, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  10. Neurotransmitters

    Description: Plasma serotonin, dopamine, norepinephrine, and epinephrine concentrations measured as indicators of neuroendocrine response, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

  11. Neurotrophic Factor

    Description: Serum Brain-Derived Neurotrophic Factor (BDNF) concentration, will be measured from venous blood samples before and after performance tests.

    Time frame: Throughout study completion, an average of 4 weeks

07

Study locations

1 site
  • Research Center for High Performance Sport. Universidad Católica de Murcia
    La Ñora, Murcia 30107, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Apr 2026, 4 months after the start.

Of 81 non-industry interventional studies with no phase under Mental Fatigue, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 94 studies reached it within 8 months; a quarter within 3 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2025
First posted
Jan 14, 2026
StartActual
Dec 1, 2025
Primary completionEst.
Apr 2026
CompletionEst.
Jun 2026
Last update
Jan 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07341789
Lead sponsor
Francisco Javier Martínez Noguera
Responsible party
Francisco Javier Martínez Noguera (Co-Principal Investigator, Universidad Católica San Antonio de Murcia) — Sponsor-investigator
First posted
Jan 14, 2026
Start date
Dec 1, 2025
Primary completion
Apr 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Jan 14, 2026

Study contacts

Francisco Javier Martinez Noguera, PhD
principal investigator · Universidad Católica San Antonio de Murcia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Vitamin B 12

Start the discussion